[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339794-105":3,"doc-detail-339794-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","transcriptomics-analysis-identified-ezrin-as-a-potential-druggable-target-in-cervical-and-gastric-cancer-cells","Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells","","A transcriptomics-driven study evaluates ezrin (EZR) as a pharmacological target in cervical squamous cell carcinoma and stomach adenocarcinoma. The work links EZR biology to oncogenesis, then uses pan-cancer TCGA analyses, differential expression, and outcome associations to prioritize cancer types. Cell models treated with NSC305787 show reduced viability and clonal growth, with molecular evidence of induced cell death and DNA damage, alongside apoptosis gene activation and suppressed survival/proliferation programs.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/transcriptomics-analysis-identified-ezrin-as-a-potential-druggable-target-in-cervical-and-gastric-cancer-cells/339794/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/transcriptomics-analysis-identified-ezrin-as-a-potential-druggable-target-in-cervical-and-gastric-cancer-cells/339794.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is ezrin (EZR) and why is it relevant to cancer progression?","Question",{"text":63,"@type":64},"Ezrin (EZR), encoded by the EZR gene, links the actin cytoskeleton to the cell membrane and supports signal transduction pathways involved in oncogenesis and disease progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study assess EZR across cancers?",{"text":68,"@type":64},"The study analyzed TCGA data for 32 cancer types, emphasizing cervical squamous cell carcinoma and stomach adenocarcinoma, and examined how EZR transcript levels relate to clinical outcomes and differentially expressed genes.",{"name":70,"@type":61,"acceptedAnswer":71},"What effects did the EZR inhibitor NSC305787 show in cervical and gastric cancer cell models?",{"text":72,"@type":64},"NSC305787 reduced cell viability and clonal growth. Molecular analyses indicate EZR inhibition promotes markers of cell death and DNA damage, increases apoptosis-associated gene expression, and decreases genes linked to survival and proliferation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339794,1790156574,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c",8,"Clinics 79 (2024) 100422  \njournal homepage: [https://www.journals.elsevier.com/clinics](https://www.journals.elsevier.com/clinics)  \n| Original articles |  |  |\n| --- | --- | --- |\n| Transcriptomics analysis identiﬁed ezrin as a potential druggable target in cervical and gastric cancer cells |  | |\n| Maria Fernanda Lopes Carvalhoa, 1, Carolina Santana Calicchioa,1, Bruna Oliveira de Almeidaa, Livia Bassani Lins de Mirandaa, Jean Carlos Lipreri da Silvaa, Keli Limaa,b,\u003Cbr>Jo~ao Agostinho Machado-Neto a, *\u003Cbr>a Department of Pharmacology, Instituto de Ci^encias Biome􀀂dicas, Universidade de S~ao Paulo, S~ao Paulo, SP, Brazil\u003Cbr>b Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, Universidade de S~ao Paulo, S~ao Paulo, SP, Brazil |  |  |\n| H I G H L I G H T S |  |  |\n| 􀀁 Ezrin (EZR) is involved in oncogenesis and disease progression.\u003Cbr>􀀁 EZR is highly expressed in cervical squamous cell carcinoma and stomach adenocarcinoma.\u003Cbr>􀀁 NSC305787, an EZR inhibitor, reduces cell viability and clonal growth in cervical and gastric cancer cells.\u003Cbr>􀀁 EZR may be a molecular target in the treatment of cervical and gastric carcinoma. |  |  |\n| A R T I C L E I N F O\u003Cbr>Keywords: Ezrin\u003Cbr>Transcriptomics\u003Cbr>Cervical cancer Gastric cancer Pharmacology | A B S T R A C T\u003Cbr>Objective: Cancer genomics and transcriptomics studies have provided a large volume of data that enables to test of hypotheses based on real data from cancer patients. Ezrin (encoded by the EZR gene) is a highly expressed protein in cancer that contributes to linking the actin cytoskeleton to the cell membrane and signal transduction pathways involved in oncogenesis and disease progression. NSC305787 is a pharmacological ezrin inhibitor with potential antineoplastic effects. In the present study, the authors prospected EZR mRNA levels in a pan-cancer analysis and identiﬁed potential cancers that could beneﬁt from anti-EZR therapies.\u003Cbr>Methods: This study analyzed TCGA data for 32 cancer types, emphasizing cervical squamous cell carcinoma and stomach adenocarcinoma. It investigated the impact of EZR transcript levels on clinical outcomes and identiﬁed differentially expressed genes. Cell lines were treated with NSC305787, and its effects were assessed through various cellular and molecular assays.\u003Cbr>Results: EZR mRNA levels are highly expressed, and their expression is associated with biologically relevant molecular processes in cervical squamous carcinoma and stomach adenocarcinoma. In cellular models of cervical and gastric cancer, NSC305787 reduces cell viability and clonal growth (p \u003C 0.05). Molecular analyses indicate that the pharmacological inhibition of EZR induces molecular markers of cell death and DNA damage, in addition, to promoting the expression of genes associated with apoptosis and inhibiting the expression of genes related to survival and proliferation.\u003Cbr>Conclusion: The present ﬁndings provide promising evidence that ezrin may be a molecular target in the treatment of cervical and gastric carcinoma. |  |\n\nIntroduction  \nIn recent years, cancer genomics and transcriptomics studies have provided and publicly deposited a large volume of data and driven the development of analysis platforms for generating and testing hypotheses based on real data from cancer patients.1,2 Among these studies, the  \ninitiative of The Cancer Genome Atlas (TCGA) stands out. These data allow evaluation of the impact of mutations or gene expression on clinical, biological, molecular, or survival outcomes.  \nEzrin (encoded by EZR) is a member of the ERM (ezrin, radixin, moesin) protein family, and when phosphorylated, it is essential for linking the actin cytoskeleton to the cell membrane.3 Ezrin binds to integral  \n*Corresponding author.  \n[E-mail address:](E-mail address: jamachadoneto@usp.br)[ jamachadoneto@usp.br](E-mail address: jamachadoneto@usp","cbCaitFqSLr9xxRp","https://ap.wps.com/l/cbCaitFqSLr9xxRp","pdf",4844804,10,"English","# Highlights\n# Article Information\n## Abstract\n## Introduction\n## Methods\n## Results\n## Conclusion","[{\"question\":\"What is ezrin (EZR) and why is it relevant to cancer progression?\",\"answer\":\"Ezrin (EZR), encoded by the EZR gene, links the actin cytoskeleton to the cell membrane and supports signal transduction pathways involved in oncogenesis and disease progression.\"},{\"question\":\"How did the study assess EZR across cancers?\",\"answer\":\"The study analyzed TCGA data for 32 cancer types, emphasizing cervical squamous cell carcinoma and stomach adenocarcinoma, and examined how EZR transcript levels relate to clinical outcomes and differentially expressed genes.\"},{\"question\":\"What effects did the EZR inhibitor NSC305787 show in cervical and gastric cancer cell models?\",\"answer\":\"NSC305787 reduced cell viability and clonal growth. Molecular analyses indicate EZR inhibition promotes markers of cell death and DNA damage, increases apoptosis-associated gene expression, and decreases genes linked to survival and proliferation.\"}]","Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells | PDF",1790032250,25,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92b7c2f80dda049f0322112adb0ea758.webp",983,1310,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/139d70fe45f99655d472ff54aca5282d.webp",982,1309,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b27de7708a8671fb7870e16d31cbc9d2.webp",981,1308,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8dda72005040f8cb51a419c688d0bde5.webp",980,1306,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,153,156,159],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":150,"show_sort_weight":151,"slug":152},9,"Religion & Spirituality",20,"religion-spirituality",{"id":151,"doc_module":4,"doc_module_name":25,"category_name":154,"show_sort_weight":151,"slug":155},"World Cup","world-cup",{"id":92,"doc_module":4,"doc_module_name":25,"category_name":157,"show_sort_weight":92,"slug":158},"Lifestyle","lifestyle",{"id":160,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":131,"slug":162},19,"General","general"]